| 2024 | 2023 | |||
|---|---|---|---|---|
| Gross margin | 65,0 k € | +154.9% | 25,5 k € | |
| EBITDA | 64,6 k € | +160.9% | 24,8 k € | |
| Operating profit | 59,3 k € | +145.3% | 24,2 k € | |
| Profit/loss | 49,1 k € | +152.3% | 19,5 k € | |
| Equity | 120,7 k € | +309.5% | 29,5 k € | |
| Total assets | 193,0 k € | +118.2% | 88,4 k € | |
| Cash | 96,2 k € | +60.2% | 60,0 k € | |
| Debts | 48,1 k € | +150.3% | 19,2 k € | |
Private limited company · Neupré · incorporated on 06/10/2022
Private limited company profitable and well capitalised. Cash position rising (+60.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
WEEXA BIOLOGICALS is a Private limited company incorporated in 2022. Its main activity is: Manufacture of fertilisers and nitrogen compounds. Its registered office is in Neupré.